COVID-19 Updates

Visit UC San Diego's Coronavirus portal for the latest information for the campus community.

CTRI Announces New KL2 Award Recipients

January 11, 2016

UC San Diego Clinical and Translational Research Institute (CTRI) has selected four KL2 awardees for 2016. As part of the CTRI Education program, KL2 awards provide a tailored mentored research experience to promising faculty clinical and translational researchers.

“These four new scholars are studying a variety of research topics, including substance abuse prevention, characteristics of neonatal hypoxia, “Big Data” approaches to cancer care, and therapeutic effects of tolcapone on cognitive control in psychosis,” said Colin Depp, PhD, Director of the Education program at CTRI. “We received 32 applications – the highest to date – and the selection committee was impressed by the breadth of research proposed and the quality of applicants.”

Three of the new KL2 scholars are from UC San Diego and, for the first time, one is from San Diego State University (SDSU).

“We were delighted to expand the program and extend eligibility to a CTRI partner institution,” said Joel Dimsdale, MD, Director of the CTRI KL2 Program. “The scholar we selected, an assistant professor in the Graduate School of Public Health at SDSU, will conduct research mentored by a multidisciplinary team spanning UC San Diego and other institutions.”

The new awardees are:

Savita G. Bhakta, MD
Department of Psychiatry, UC San Diego
Project Title: Tolcapone Effects on Cognitive Control in Psychosis: Neural Basis and Biomarker Predictors

Farhad Imam, MD, PhD
Department of Pediatrics, UC San Diego
Project Title: Genetic and Molecular Characterization of Hypoxia Resistance via Preconditioning for Prevention of Brain Injury in Term and Preterm Newborn Infants

Joanna Jacobus, PhD
Department of Psychiatry, UC San Diego
Project Title: Cognitive Bias Modification Training to Reduce Marijuana Use in Adolescents

Caroline A. Thompson, PhD, MPH
Division of Epidemiology and Biostatistics, San Diego State University
Project Title: Using Electronic Health Records to Understand Pathways of Breast Cancer Screening and Care

KL2 awardees receive up to three years of support from the CTRI and will be engaged in research and structured and experiential methodology-focused training, such as through our Clinical Research Enhancement through Supplemental Training (CREST) program. In addition, four researchers previously awarded will continue to receive KL2 support this year.

Click here to view the new KL2 awardees and their research project abstracts, as well as a complete listing of the CTRI KL2 awardees.

About UC San Diego Altman Clinical and Translational Research Institute:

UC San Diego Altman Clinical and Translational Research Institute (ACTRI) is part of a national Clinical and Translational Science Award consortium, led by the National Institutes of Health National Center for Advancing Translational Science. Established in 2010, ACTRI provides infrastructure and support for basic, translational and clinical research throughout the San Diego region to bring discoveries from the laboratory to the bedside, and facilitates training and education of the next generation of researchers. ACTRI carries out its activities in collaboration with institutional and corporate partners and currently has more than 1,500 members.